Royalty Pharma Financial Health

How is Royalty Pharma's financial position?

[object Object] Score

3/6

Financial Health Score 3/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: RPRX's short term assets ($2.3B) exceed its short term liabilities ($1.1B).

Long Term Liabilities: RPRX's short term assets ($2.3B) do not cover its long term liabilities ($6.1B).


Debt to Equity History and Analysis

Debt Level: RPRX's net debt to equity ratio (54.1%) is considered high.

Reducing Debt: Insufficient data to determine if RPRX's debt to equity ratio has reduced over the past 5 years.

Debt Coverage: RPRX's debt is well covered by operating cash flow (29%).

Interest Coverage: RPRX's interest payments on its debt are well covered by EBIT (6.6x coverage).


Balance Sheet


Discover healthy companies